XORTX Therapeutics Inc (XRTX)
2.50
+0.15
(+6.38%)
USD |
NASDAQ |
May 17, 16:00
2.50
0.00 (0.00%)
After-Hours: 20:00
XORTX Therapeutics Price: 2.50 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 2.49 | 2.54 | 2.310 | 2.500 | 7384.00 |
May 16, 2024 | 2.43 | 2.50 | 2.35 | 2.35 | 11978.00 |
May 15, 2024 | 2.59 | 2.650 | 2.420 | 2.49 | 12548.00 |
May 14, 2024 | 2.62 | 2.62 | 2.39 | 2.45 | 18445.00 |
May 13, 2024 | 2.63 | 2.650 | 2.43 | 2.51 | 5799.00 |
May 10, 2024 | 2.66 | 2.778 | 2.52 | 2.52 | 21368.00 |
May 09, 2024 | 2.636 | 2.750 | 2.63 | 2.68 | 14115.00 |
May 08, 2024 | 2.73 | 2.82 | 2.71 | 2.71 | 6051.00 |
May 07, 2024 | 3.13 | 3.13 | 2.65 | 2.66 | 38600.00 |
May 06, 2024 | 2.73 | 2.73 | 2.560 | 2.65 | 6763.00 |
May 03, 2024 | 2.552 | 2.847 | 2.55 | 2.677 | 3591.00 |
May 02, 2024 | 2.52 | 2.70 | 2.52 | 2.599 | 4294.00 |
May 01, 2024 | 2.626 | 2.65 | 2.535 | 2.562 | 2595.00 |
Apr 30, 2024 | 2.698 | 2.75 | 2.55 | 2.55 | 10521.00 |
Apr 29, 2024 | 3.12 | 3.24 | 2.56 | 2.645 | 48519.00 |
Apr 26, 2024 | 2.75 | 3.00 | 2.530 | 2.93 | 25186.00 |
Apr 25, 2024 | 2.79 | 2.84 | 2.510 | 2.59 | 26337.00 |
Apr 24, 2024 | 2.96 | 3.000 | 2.846 | 2.902 | 10960.00 |
Apr 23, 2024 | 2.700 | 2.944 | 2.700 | 2.94 | 8353.00 |
Apr 22, 2024 | 2.82 | 3.00 | 2.82 | 3.00 | 23414.00 |
Apr 19, 2024 | 2.955 | 3.00 | 2.90 | 2.997 | 13020.00 |
Apr 18, 2024 | 3.16 | 3.16 | 2.83 | 3.050 | 30676.00 |
Apr 17, 2024 | 3.03 | 3.23 | 3.00 | 3.17 | 4048.00 |
Apr 16, 2024 | 3.10 | 3.180 | 3.060 | 3.10 | 8604.00 |
Apr 15, 2024 | 3.37 | 3.550 | 3.11 | 3.22 | 7909.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.01
Minimum
Dec 28 2023
64.45
Maximum
Sep 07 2021
12.50
Average
11.59
Median
Aug 01 2019
Price Benchmarks
ImmunoPrecise Antibodies Ltd | 1.18 |
Acasti Pharma Inc | 2.69 |
Aurinia Pharmaceuticals Inc | 5.76 |
Edesa Biotech Inc | 4.65 |
Lexaria Bioscience Corp | 3.15 |
Price Related Metrics
Price to Book Value | 1.564 |
Earnings Yield | -44.41% |
Market Cap | 7.259M |